MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6306-1296-1303$20.00
Mol Pharmacol 63:1296-1303, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fourcade, S.
Right arrow Articles by Bugaut, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fourcade, S.
Right arrow Articles by Bugaut, M.

Thyroid Hormone Induction of the Adrenoleukodystrophy-Related Gene (ABCD2)

Stéphane Fourcade, Stéphane Savary, Catherine Gondcaille, Johannes Berger, Angela Netik, Françoise Cadepond, Martine El Etr, Brunhilde Molzer, and Maurice Bugaut

Laboratoire de Biologie Moléculaire et Cellulaire, Université de Bourgogne, Dijon, France (S.F., S.S., C.G., M.B.); Brain Research Institute (J.B., A.N.) and Institute of Neurology (B.M.), University of Vienna, Vienna, Austria; and Institut National de la Santé et de la Recherche Médicale U488, Le Kremlin-Bicêtre, France (F.C., M.E.E.)

X-linked adrenoleukodystrophy (X-ALD) is a demyelinating disorder associated with impaired very-long-chain fatty-acid (VLCFA) {beta}-oxidation caused by mutations in the ABCD1 (ALD) gene that encodes a peroxisomal membrane ABC transporter. ABCD2 (ALDR) displays partial functional redundancy because when overexpressed, it is able to correct the X-ALD biochemical phenotype. The ABCD2 promoter contains a putative thyroid hormone-response element conserved in rodents and humans. In this report, we demonstrate that the element is capable of binding retinoid X receptor and 3,5,3'-tri-iodothyronine (T3) receptor (TR{beta}) as a heterodimer and mediating T3 responsiveness of ABCD2 in its promoter context. After a T3 treatment, an induction of the ABCD2 gene was observed in the liver of normal rats but not that of TR{beta}-/- mice. ABCD2 was not induced in the brain of the T3-treated rats. However, we report for the first time that induction of the ABCD2 redundant gene is feasible in myelin-producing cells (differentiated CG4 oligodendrocytes). The induction was specific for this cell type because it did not occur in astrocytes. Furthermore, we observed T3 induction of ABCD2 in human and mouse ABCD1-deficient fibroblasts, which was correlated with normalization of the VLCFA {beta}-oxidation. Finally, ABCD3 (PMP70), a close homolog of ABCD2, was also induced by T3 in the liver of control rats, but not that of TR{beta}-/- mice, and in CG4 oligodendrocytes.


Received September 19, 2002; accepted February 21, 2003

Address correspondence to: Dr. Maurice Bugaut, LBMC, Faculté des Sciences Gabriel, 6 Bd Gabriel, 21000 Dijon, France. E-mail: mbugaut{at}u-bourgogne.fr




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
I. Weinhofer, M. Kunze, H. Rampler, A. L. Bookout, S. Forss-Petter, and J. Berger
Liver X Receptor {alpha} Interferes with SREBP1c-mediated Abcd2 Expression: NOVEL CROSS-TALK IN GENE REGULATION
J. Biol. Chem., December 16, 2005; 280(50): 41243 - 41251.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
C. Gondcaille, M. Depreter, S. Fourcade, M. R. Lecca, S. Leclercq, P. G.P. Martin, T. Pineau, F. Cadepond, M. ElEtr, N. Bertrand, et al.
Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator
J. Cell Biol., April 11, 2005; 169(1): 93 - 104.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Pujol, I. Ferrer, C. Camps, E. Metzger, C. Hindelang, N. Callizot, M. Ruiz, T. Pampols, M. Giros, and J. L. Mandel
Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy
Hum. Mol. Genet., December 1, 2004; 13(23): 2997 - 3006.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics